Hepatocellular Carcinoma: Clinical Insights on Expanding Systemic Treatment Options

In this on-demand Webcast and downloadable slideset, CCO’s expert faculty explore optimal care for patients for HCC, including current systemic therapy options and individualizing treatment based on patient and disease characteristics, as well as promising investigational targeted therapies.
Tanios Bekaii-Saab
Tanios Bekaii-Saab, MD, FACP
Program Director
Tanios Bekaii-Saab
Tanios Bekaii-Saab, MD, FACP
Peter R. Galle, MD, PhD
Tim F. Greten, MD

Downloadable Slidesets

In this downloadable slideset, Tanios Bekaii-Saab, MD, FACP, reviews the key data on approved systemic therapies and optimal management of HCC.

Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP Released: June 7, 2017

In this downloadable slideset, Peter R. Galle, MD, PhD, reviews the key data on emerging targeted therapies and novel targets for HCC.

Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP Released: June 7, 2017

In this downloadable slideset, Tim F. Greten, MD, reviews the rationale for immunotherapy in the treatment of HCC and promising data on the use of immune checkpoint inhibitors.

Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP Released: June 7, 2017

On-Demand Webcast

In this on-demand Webcast of the live symposium in Chicago, our distinguished faculty provide insight into the key emerging and practice-changing approaches to systemic therapy in advanced HCC.

Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP
Program Director
Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP Peter R. Galle, MD, PhD Tim F. Greten, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: July 11, 2017 Expiration: July 10, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by educational grants from
Bayer Healthcare Pharmaceuticals Inc.
Eisai

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?